Share of the population living with HIV receiving antiretroviral therapy in United Kingdom
United Kingdom: Share of the population living with HIV receiving antiretroviral therapy was 94.0% in 2023. ▬ Flat
Latest (2023)
94.0%
Change on year
up 1.5%
World rank
7th
of 149 countries
All-time high
94.0%
in 2023
All-time low
89.0%
in 2016
Years of data
8
2016–2023
Share of the population living with HIV receiving antiretroviral therapy in United Kingdom, 2016–2023
Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.
Analysis
In 2023, share of the population living with hiv receiving antiretroviral therapy in United Kingdom stood at 94.0%. That is the highest value across all 8 years on record.
The figure is up 1.5% on the previous year and up 5.7% over ten years.
United Kingdom ranks 7th of 149 countries on this measure, in the top 10%.
Share of the population living with HIV receiving antiretroviral therapy in United Kingdom, year by year
| Year | % | Change |
|---|---|---|
| 2016 | 89.0% | — |
| 2017 | 90.7% | +1.9% |
| 2018 | 90.6% | -0.1% |
| 2019 | 92.7% | +2.3% |
| 2020 | 91.2% | -1.7% |
| 2021 | 91.3% | +0.1% |
| 2022 | 92.6% | +1.5% |
| 2023 | 94.0% | +1.5% |
United Kingdom compared with similar countries
- United Kingdom's 94.0% is above the median for high income countries, which is 79.3%, 1.2× the median. (42 countries reporting)
- United Kingdom's 94.0% is above the median for Europe & Central Asia, which is 82.9%, 1.1× the median. (34 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 90.8% | 89.0% | 92.7% | 4 |
| 2020s | 92.3% | 91.2% | 94.0% | 4 |
Countries ranked near United Kingdom
More reference data data for United Kingdom
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 3.13 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 3.97 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 13.26 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 1.01 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 13.26 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 10.5 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 6.51 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 15.81 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 59.34 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 5.48 (2050)
Frequently asked questions
- What is share of the population living with hiv receiving antiretroviral therapy in United Kingdom?
- Share of the population living with hiv receiving antiretroviral therapy in United Kingdom was 94.0% in 2023, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
- What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in United Kingdom?
- The highest recorded value was 94.0% in 2023.
- What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in United Kingdom?
- The lowest recorded value was 89.0% in 2016.
- How does United Kingdom rank for share of the population living with hiv receiving antiretroviral therapy?
- United Kingdom ranks 7th out of 149 countries with data for 2023.
- Is share of the population living with hiv receiving antiretroviral therapy rising or falling in United Kingdom?
- Over the last ten years it is up 5.7%. The long-run trend across the full record is flat.
- Where does this United Kingdom data come from?
- The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.